Presentation Summary : The Role of SGLT-2 Inhibitors in the Management of Patients with Type 2 Diabetes Lawrence Blonde, MD Director, Ochsner Diabetes Clinical Research Unit,
Source : http://www.nysafp.org/images/uploads/misc/1326909268_SGLT-2%20powerpoint%20AFP.ppt
Presentation Summary : Glycemic Management in Type 2 Diabetes * ... Exenatide XR Bydureon Liraglutide Victoza SGLT2 inhibitors Increase urinary excretion of glucose Canagliflozin ...
Source : http://outpatient.aace.com/sites/all/files/T2DM_S5_Treatment_041813.ppt
Presentation Summary : Author: ETreventi Created Date: 11/13/2014 11:35:01 Title: SGLT2 Inhibitors in the Modern Era: Why and Where? Last modified by: ETreventi
Source : http://img.medscape.com/images/835/056/835056_slide.pptx
Presentation Summary : Objectives. Recall the mechanism of action of SGLT2 inhibitors. List potential benefits and concerns of SGLT2 inhibitors. Recognize available SGLT2 inhibitors and ...
Source : http://www.indianapharmacists.org/Files/2014%20ACON%20Clinicl%20Pearls/Clinical%20Pearls%20LIRA.pptx
Presentation Summary : Role of the Kidney in T2DM - WorldWIDE Diabetes
Source : http://www.worldwidediabetes.org/wp-content/downloads/role-of-the-kidney.ppt
Presentation Summary : Rationale for SGLT2 Inhibitors. The SGLT2 is a glucose transporter responsible for 90% of glucose reabsorption. Selective SGLT2 inhibitors could reduce blood glucose ...
Source : http://www.inosteo.org/UserFiles/File/PowerPoint/2012%20IOA%20Annual%20Convention/Saturday/Advances%20in%20Type%202%20Diabetes.Novel%20Agents%20that%20Target%20the%20Kidney.Freeman.pptx
Presentation Summary : SGLT2 Inhibitors Lower Renal Threshold for Glucose Excretion. SGLT2 Inhibitors. Blood Pressure Effects of SGLT2 Inhibitors. SGLT2 Adverse Effects (Well Tolerated)
Source : http://img.medscape.com/images/829/831/829831_slides.pptx
Presentation Summary : Several selective SGLT2 inhibitors (SGLT2i) ... Assuming the SGLT2 transporter is uniformly distributed along the length L of the effective tubule, ...
Source : http://www.go-acop.org/sites/default/files/webform/posters/Nucci-SGLT2i-Poster-ACoP-2011.ppt
Presentation Summary : Sodium-Glucose-Cotransporter-2 (SGLT2) Inhibitors: The Latest Class of Oral Agents. Canagliflozin and Dapagliflozin are the first FAD approved SGLT-2 In.
Source : http://adc2014.com/presentations/Osama-Hamdy/001.pptx
Presentation Summary : Model-Based Meta-Analysis of HbA1c, Weight, and FPG in Type 2 Diabetes: Focus on SGLT2 inhibitors William S. Denney and Gianluca Nucci Pfizer Global R&D, Groton/New ...
Source : http://www.go-acop.org/sites/default/files/webform/posters/Denney-SGLT-2%20Poster-ACoP%202011.ppt
Presentation Summary : Sodium-glucose-cotransporter-2 (SGLT2) inhibitors. ... Management of type 2 diabetes: new and future developments in treatment. The Lancet, Vol 378. July 9 2011, 182-195.
Source : http://www.segageriatrics.com/wp/wp-content/uploads/2011/09/New-DMII-Treatments.pptx
Presentation Summary : Objectives. Pharmacists will be able to: Describe SGLT2 inhibitors. Compare available SGLT-2 inhibitors. Identifyideal candidates for SGLT2 inhibitors
Source : http://www.drsamrotation.com/uploads/1/9/8/6/19863509/jardiance_presesentation_rahul.pptx
Presentation Summary : Distinguish the unique differences between new SGLT2 inhibitors and discuss the clinical implications of these differences on appropriate patient selection .
Source : http://www.arkansasafp.org/wp-content/uploads/Niyaz-Gosmanov-M.D..pptx
Presentation Summary : Review the role of the kidney in the maintenance of normal glucose homeostasis. 6. Discuss the role of the SGLT2 inhibitors in the treatment of Type 2 DM. 7. Define ...
Source : http://www.sanap.org/Diabetes_flyer_2014_registration_form.ppt
Presentation Summary : ... should be stopped at GFR 30 ml/min Insulin has prolonged halflife Thiazolindinediones may cause volume and bone issues SGLT2 inhibitors less efficacious under ...
Source : http://www.prhc.on.ca/Assets/Uploaded-CMS-Files/DR.%20HANSONChronic%20Kidney%20Disease%20and%20Diabetes%201-c5ea0782-e0a2-4d99-9130-599242cdff20.ppt
Presentation Summary : SGLT2 Inhibitors. Pros. Cons. Easily added to anything, and/or insulin in DM1 & 2 . Simple & dose response. ... Diabetes Obes Metab.January.2012/p1/lines A6-A8; ...
Source : http://www.ruraldoctors.ie/wp-content/uploads/2014/03/Dr.MC-Durkan-Whats-New-Diabetes.pptx
Presentation Summary : inhibitors, Tyrosinase Inhibitor compounds, process, uses. Europe. ... Sirona’s SGLT2 inhibitor grows its value for licensing opportunities everywhere else in the ...
Source : http://www.sironabiochem.com/wp-content/uploads/2014/02/SBM-Introduction-01292014.pptx
Presentation Summary : Inhibitors of reabsorption of glucose (SGLT2 inhibitors): ... Patients periodically develop ketoacidosis. Diabetes mellitus (DM) Type 2 DM ...
Source : http://www.medpharm-sofia.eu/files/DIR%205/Section%205/Diabet4E.ppt
Presentation Summary : Update in Diabetes Mellitus Chaicharn Deerochanawong M.D. Professor of Medicine Diabetes and Endocrinology Unit Department of Medicine, Rangsit Medical School
Source : http://www.tlaa.org/2012/timac_rename.php?timac_pdf_id=11
Presentation Summary : SGLT2 Inhibitors. Dapagliflozin. Blood glucose monitoring may be required in patients: with acute illness. ... PowerPoint Presentation Last modified by: ICT Services
Source : http://www.westsuffolkccg.nhs.uk/wp-content/uploads/2014/02/WSCCG-BGTS-Presentation-FINAL-Jan2014-FOR-WEBSITE.pptx
Presentation Summary : Glycemic Management in Type 2 Diabetes. ... SGLT2 Inhibitors. SGLT2, sodium-glucose cotransporter 2. DeFronzo RA, et al. Diabetes . Obes. Metab
Source : http://outpatient.aace.com/sites/all/files/T2DM-S5-New-Antidiabetic-Therapies-080614.pptx